000856855 001__ 856855
000856855 005__ 20210129235417.0
000856855 0247_ $$2doi$$a10.1039/C8MD00454D
000856855 0247_ $$2ISSN$$a2040-2503
000856855 0247_ $$2ISSN$$a2040-2511
000856855 0247_ $$2altmetric$$aaltmetric:50982181
000856855 0247_ $$2WOS$$aWOS:000475806000003
000856855 037__ $$aFZJ-2018-06194
000856855 082__ $$a540
000856855 1001_ $$0P:(DE-HGF)0$$aReßing, Nina$$b0
000856855 245__ $$aDesign, Synthesis and Biological Evaluation of β-Peptoid-Capped HDAC Inhibitors with Anti-Neuroblastoma and Anti-Glioblastoma Activity
000856855 260__ $$aCambridge$$bRSC Publ.$$c2019
000856855 3367_ $$2DRIVER$$aarticle
000856855 3367_ $$2DataCite$$aOutput Types/Journal article
000856855 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1564051694_26959
000856855 3367_ $$2BibTeX$$aARTICLE
000856855 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000856855 3367_ $$00$$2EndNote$$aJournal Article
000856855 520__ $$aHistone deacetylases (HDACs) have been identified as promising epigenetic drug targets for the treatment of neuroblastomaand glioblastoma. In this work, we have rationally designed a novel type of peptoid‐based histone deacetylase inhibitors(HDACi). A mini library of β‐peptoid‐capped HDACi was synthesized using a four‐step protocol. All compounds were screenedin biochemical assays for its inhibition of HDAC1 and HDAC6 and docking studies were performed to rationalize the observedselectivity profile. The synthesized compounds were further examined for tumor cell‐inhibitory activity against a panel ofneuroblastoma and glioblastoma cell lines. In particular, non‐selective compounds with potent activity against HDAC1 andHDAC6 showed strong antiproliferative effects. The most promising HDACi, compound 6i, displayed submicromolar tumorcell‐inhibitory potential (IC50: 0.21 – 0.67 μM) against all five cancer cell lines investigated and exceeded the activity of theFDA‐approved HDACi vorinostat.
000856855 536__ $$0G:(DE-HGF)POF3-511$$a511 - Computational Science and Mathematical Methods (POF3-511)$$cPOF3-511$$fPOF III$$x0
000856855 536__ $$0G:(DE-Juel1)hkf7_20170501$$aForschergruppe Gohlke (hkf7_20170501)$$chkf7_20170501$$fForschergruppe Gohlke$$x1
000856855 588__ $$aDataset connected to CrossRef
000856855 7001_ $$0P:(DE-HGF)0$$aMarquardt, Viktoria$$b1
000856855 7001_ $$0P:(DE-Juel1)174133$$aGertzen, Christoph$$b2$$ufzj
000856855 7001_ $$0P:(DE-HGF)0$$aSchöler, Andrea$$b3
000856855 7001_ $$0P:(DE-HGF)0$$aSchramm, Alexander$$b4
000856855 7001_ $$0P:(DE-HGF)0$$aKurz, Thomas$$b5
000856855 7001_ $$0P:(DE-Juel1)172663$$aGohlke, Holger$$b6$$ufzj
000856855 7001_ $$0P:(DE-HGF)0$$aAigner, Achim$$b7
000856855 7001_ $$0P:(DE-HGF)0$$aRemke, Marc$$b8
000856855 7001_ $$0P:(DE-HGF)0$$aHansen, Finn Kristian$$b9$$eCorresponding author
000856855 773__ $$0PERI:(DE-600)2545949-1$$a10.1039/C8MD00454D$$gp. 10.1039.C8MD00454D$$n7$$p1109-1115$$tMedChemComm$$v10$$x2040-2511$$y2019
000856855 8564_ $$uhttps://juser.fz-juelich.de/record/856855/files/beta%20peptoids%20revision.pdf$$yRestricted
000856855 8564_ $$uhttps://juser.fz-juelich.de/record/856855/files/c8md00454d.pdf$$yRestricted
000856855 8564_ $$uhttps://juser.fz-juelich.de/record/856855/files/beta%20peptoids%20revision.pdf?subformat=pdfa$$xpdfa$$yRestricted
000856855 8564_ $$uhttps://juser.fz-juelich.de/record/856855/files/c8md00454d.pdf?subformat=pdfa$$xpdfa$$yRestricted
000856855 909CO $$ooai:juser.fz-juelich.de:856855$$pVDB
000856855 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)174133$$aForschungszentrum Jülich$$b2$$kFZJ
000856855 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)172663$$aForschungszentrum Jülich$$b6$$kFZJ
000856855 9131_ $$0G:(DE-HGF)POF3-511$$1G:(DE-HGF)POF3-510$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lSupercomputing & Big Data$$vComputational Science and Mathematical Methods$$x0
000856855 9141_ $$y2019
000856855 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium
000856855 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMEDCHEMCOMM : 2017
000856855 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000856855 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000856855 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000856855 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000856855 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000856855 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000856855 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000856855 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000856855 920__ $$lyes
000856855 9201_ $$0I:(DE-Juel1)JSC-20090406$$kJSC$$lJülich Supercomputing Center$$x0
000856855 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x1
000856855 9201_ $$0I:(DE-Juel1)NIC-20090406$$kNIC$$lJohn von Neumann - Institut für Computing$$x2
000856855 980__ $$ajournal
000856855 980__ $$aVDB
000856855 980__ $$aI:(DE-Juel1)JSC-20090406
000856855 980__ $$aI:(DE-Juel1)ICS-6-20110106
000856855 980__ $$aI:(DE-Juel1)NIC-20090406
000856855 980__ $$aUNRESTRICTED
000856855 981__ $$aI:(DE-Juel1)IBI-7-20200312